Low-dose interleukin-2 for the treatment of systemic lupus erythematosus: A systematic review and meta-analysis https://www.medrxiv.org/content/10.1101/2022.12.02.22283038
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.